SGLT-2i and Cardiovascular Prognosis | Bentham Science Publishers

2000

Volume 26, Issue 32

ISSN: 1381-6128
E-ISSN: 1873-4286

s SGLT-2i and Cardiovascular Prognosis
By Gerasimos Siasos, Panagiota K. Stampouloglou, Evanthia Bletsa, Stavroula A. Paschou, Evangelos Oikonomou, Georgios Giannopoulos, Spyridon Deftereos, Michael W. Cleman and Dimitrios Tousoulis
Source: Current Pharmaceutical Design, Volume 26, Issue 32, Sep 2020, p. 3905 - 3907
DOI: https://doi.org/10.2174/138161282632200811172751
- Available online: 01 Sep 2020

Preview this article:

There is no abstract available.

© Bentham Science Publishers

Article metrics loading...

/content/journals/cpd/10.2174/138161282632200811172751

2020-09-01

2025-10-21

From This Site

/content/journals/cpd/10.2174/138161282632200811172751

dcterms_title,dcterms_subject,pub_keyword

-contentType:Contributor -contentType:Concept -contentType:Institution

10

5

Loading full text...

Full text loading...

/content/journals/cpd/10.2174/138161282632200811172751

Article Type: Other

Keyword(s): cardiovascular; CVD; glucose; heart failure; SGLT-2i; Type 2 diabetes mellitus

Most Cited Most Cited RSS feed

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error

Please enter a valid_number test